GRM3 Gene

HGNC Family	G protein-coupled receptors, Glutamate receptors
Name	glutamate receptor, metabotropic 3
Description	L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. [provided by RefSeq, Jul 2008]
Summary	{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n The metabotropic glutamate receptor 3 (mGluR3), encoded by the gene "}, {"type": "b", "children": [{"type": "t", "text": "GRM3"}]}, {"type": "t", "text": ", has emerged as a key modulator of glutamatergic neurotransmission in both neuronal and glial systems. Genetic association studies have linked GRM3 variants to increased risk for schizophrenia and related psychiatric disorders as well as to deficits in cognitive domains such as working memory and executive function."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " Functional neuroimaging findings further indicate that GRM3 risk variants can lead to inefficient prefrontal cortex engagement—often in concert with dopaminergic regulators like COMT—thereby altering cortical signaling during working memory tasks."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n At the cellular level, mGluR3 plays a pivotal role in moderating extracellular glutamate levels. In astrocytes and neurons, activation of mGluR3 has been shown to regulate the expression of glutamate transporters, which in turn can influence synaptic plasticity and may offer neuroprotective benefits."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Alterations in mGluR3 function, whether by mutated receptor isoforms, alternative splicing, or changes in expression levels, have been observed in postmortem studies of patients with schizophrenia"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": ", and GRM3 polymorphisms may even predict clinical response to antipsychotic treatments such as olanzapine."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond its role in psychiatric conditions, recent work has revealed that somatic mutations in GRM3 can drive tumorigenic processes in melanoma by selectively modulating the phosphorylation of MEK, thereby enhancing anchorage‐independent growth and cellular migration."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In parallel, preclinical studies using GRM3 knockout mouse models have demonstrated that loss of mGluR3 function leads to impairments in working memory and altered responses to psychotomimetic challenges, reinforcing the receptor’s critical role in higher cognitive processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Finally, interactions between GRM3 risk haplotypes and glutamate transporter systems—for example, associations with reduced EAAT2 expression in the prefrontal cortex—underscore a broader influence of mGluR3 on glutamatergic signaling and synaptic homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " Collectively, these findings highlight the multifunctional role of mGluR3 in modulating synaptic transmission, regulating cognitive function, and in its emerging potential as a pharmacological target in both neuropsychiatric and oncological disorders.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Michael F Egan, Richard E Straub, Terry E Goldberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0405077101"}], "href": "https://doi.org/10.1073/pnas.0405077101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15310849"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15310849"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "M Daniele Fallin, Virginia K Lasseter, Dimitrios Avramopoulos, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/497703"}], "href": "https://doi.org/10.1086/497703"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16380905"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16380905"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Qi Chen, Guang He, Qingying Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2004.07.002"}], "href": "https://doi.org/10.1016/j.schres.2004.07.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15567072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15567072"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hao-Yang Tan, Qiang Chen, Steven Sust, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0610125104"}], "href": "https://doi.org/10.1073/pnas.0610125104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17636131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17636131"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Eleonora Aronica, Jan A Gorter, Helen Ijlst-Keizers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Neurosci (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1460-9568.2003.02657.x"}], "href": "https://doi.org/10.1046/j.1460-9568.2003.02657.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12786977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12786977"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "P J Harrison, L Lyon, L J Sartorius, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Psychopharmacol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0269881108089818"}], "href": "https://doi.org/10.1177/0269881108089818"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18541626"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18541626"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Corrado Corti, Luca Crepaldi, Silvia Mion, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Altered dimerization of metabotropic glutamate receptor 3 in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biol Psychiatry (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopsych.2006.12.005"}], "href": "https://doi.org/10.1016/j.biopsych.2006.12.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17531207"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17531207"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Leah J Sartorius, Daniel R Weinberger, Thomas M Hyde, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.npp.1301669"}], "href": "https://doi.org/10.1038/sj.npp.1301669"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18256595"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18256595"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Jeffrey R Bishop, Vicki L Ellingrod, Jessica Moline, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2005.04.001"}], "href": "https://doi.org/10.1016/j.schres.2005.04.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15913960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15913960"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Todd D Prickett, Xiaomu Wei, Isabel Cardenas-Navia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.950"}], "href": "https://doi.org/10.1038/ng.950"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21946352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21946352"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Nicolas Rabas, Sarah Palmer, Louise Mitchell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PINK1 drives production of mtDNA-containing extracellular vesicles to promote invasiveness."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.202006049"}], "href": "https://doi.org/10.1083/jcb.202006049"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34623384"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34623384"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Mira Lainiola, Chiara Procaccini, Anni-Maija Linden "}, {"type": "b", "children": [{"type": "t", "text": "mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Behav Brain Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbr.2014.03.008"}], "href": "https://doi.org/10.1016/j.bbr.2014.03.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24631392"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24631392"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Louisa Lyon, Philip W J Burnet, James N C Kew, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Fractionation of spatial memory in GRM2/3 (mGlu2/mGlu3) double knockout mice reveals a role for group II metabotropic glutamate receptors at the interface between arousal and cognition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropsychopharmacology (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/npp.2011.145"}], "href": "https://doi.org/10.1038/npp.2011.145"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21832989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21832989"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Marco Spangaro, Marta Bosia, Andrea Zanoletti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2012.06.030"}], "href": "https://doi.org/10.1016/j.neulet.2012.06.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22728822"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22728822"}]}]}]}
Synonyms	MGLUR3, MGLU3, GPRC1C
Proteins	GRM3_HUMAN
NCBI Gene ID	2913
API
Download Associations
Predicted Functions
Co-expressed Genes
Expression in Tissues and Cell Lines

Functional Associations

GRM3 has 4,870 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 120 datasets.

Click the + buttons to view associations for GRM3 from the datasets below.

If available, associations are ranked by standardized value

Harmonizome 3.0

GRM3 Gene

Functional Associations

Please acknowledge the Harmonizome in your publications by citing the following reference(s):

	Dataset	Summary
	Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of GRM3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles	tissues with high or low expression of GRM3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
	Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles	tissue samples with high or low expression of GRM3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray	tissue samples with high or low expression of GRM3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
	Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq	tissue samples with high or low expression of GRM3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
	Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles	tissues with high or low expression of GRM3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
	BioGPS Cell Line Gene Expression Profiles	cell lines with high or low expression of GRM3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
	BioGPS Human Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of GRM3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
	BioGPS Mouse Cell Type and Tissue Gene Expression Profiles	cell types and tissues with high or low expression of GRM3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
	Carcinogenome Chemical Perturbation Carcinogenicity Signatures	small molecule perturbations changing expression of GRM3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
	CCLE Cell Line Gene CNV Profiles	cell lines with high or low copy number of GRM3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
	CCLE Cell Line Gene Expression Profiles	cell lines with high or low expression of GRM3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
	CellMarker Gene-Cell Type Associations	cell types associated with GRM3 gene from the CellMarker Gene-Cell Type Associations dataset.
	ChEA Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of GRM3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
	ChEA Transcription Factor Targets	transcription factors binding the promoter of GRM3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
	ChEA Transcription Factor Targets 2022	transcription factors binding the promoter of GRM3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
	CMAP Signatures of Differentially Expressed Genes for Small Molecules	small molecule perturbations changing expression of GRM3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores	cellular components containing GRM3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
	COMPARTMENTS Curated Protein Localization Evidence Scores 2025	cellular components containing GRM3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores	cellular components co-occuring with GRM3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
	COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025	cellular components co-occuring with GRM3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
	COSMIC Cell Line Gene CNV Profiles	cell lines with high or low copy number of GRM3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
	COSMIC Cell Line Gene Mutation Profiles	cell lines with GRM3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
	CTD Gene-Chemical Interactions	chemicals interacting with GRM3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
	CTD Gene-Disease Associations	diseases associated with GRM3 gene/protein from the curated CTD Gene-Disease Associations dataset.
	dbGAP Gene-Trait Associations	traits associated with GRM3 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset.
	DepMap CRISPR Gene Dependency	cell lines with fitness changed by GRM3 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
	DEPOD Substrates of Phosphatases	phosphatases that dephosphorylate GRM3 protein from the curated DEPOD Substrates of Phosphatases dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores	diseases associated with GRM3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Experimental Gene-Disease Association Evidence Scores 2025	diseases associated with GRM3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores	diseases co-occuring with GRM3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
	DISEASES Text-mining Gene-Disease Association Evidence Scores 2025	diseases co-occuring with GRM3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
	DisGeNET Gene-Disease Associations	diseases associated with GRM3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
	DisGeNET Gene-Phenotype Associations	phenotypes associated with GRM3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
	DrugBank Drug Targets	interacting drugs for GRM3 protein from the curated DrugBank Drug Targets dataset.
	ENCODE Histone Modification Site Profiles	histone modification site profiles with high histone modification abundance at GRM3 gene from the ENCODE Histone Modification Site Profiles dataset.
	ENCODE Transcription Factor Binding Site Profiles	transcription factor binding site profiles with transcription factor binding evidence at the promoter of GRM3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
	ENCODE Transcription Factor Targets	transcription factors binding the promoter of GRM3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
	ESCAPE Omics Signatures of Genes and Proteins for Stem Cells	PubMedIDs of publications reporting gene signatures containing GRM3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
	GAD Gene-Disease Associations	diseases associated with GRM3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.